baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BNP Paribas Discount Zert LONN 26.../ DE000PC4JLP6 /

2024-05-14 4:20:56 PM	Chg.-0.620	Bid5:19:55 PM	Ask5:19:55 PM	Underlying	Strike price	Expiration date	Option type
418.950EUR	-0.15%	- Bid Size: -	- Ask Size: -	LONZA N	- CHF	2024-09-26	Call

GlobeNewswire 05-14 Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights

GlobeNewswire 05-08 Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 05-08 Maravai LifeSciences Reports First Quarter 2024 Financial Results

GlobeNewswire 04-04 Galapagos showcases innovative approach in hematological cancer care with clinical and translational...

GlobeNewswire 04-04 Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’...

GlobeNewswire 02-27 Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire 02-15 Galapagos presents at EBMT-EHA annual meeting 2024

GlobeNewswire 01-04 Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further exp...

GlobeNewswire 2023-12-19 Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufacture...

GlobeNewswire 2023-12-09 Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...

GlobeNewswire 2023-12-07 Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at A...

GlobeNewswire 2023-12-07 Business Update

GlobeNewswire 2023-11-06 Vaxcyte Reports Third Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire 2023-11-01 Dr. Hartmut Tintrup joins Cellbox Solutions GmbH as new CEO

GlobeNewswire 2023-10-19 Viralgen welcomes back Andy Holt as CCO

GlobeNewswire 2023-10-16 Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumoc...

GlobeNewswire 2023-10-02 Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer

GlobeNewswire 2023-09-20 Oxford Biomedica Plc - INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023

GlobeNewswire 2023-09-19 Galapagos appoints Simon Sturge to its Board of Directors

GlobeNewswire 2023-09-13 Culture Biosciences Appoints Darcy Birse as Chief Commercial Officer

GlobeNewswire 2023-09-07 Institutional Investor Launches 2023 Developed Europe & Emerging Emea Executive Team Rankings

GlobeNewswire 2023-09-05 Ascendis Pharma Reports Second Quarter 2023 Financial Results

GlobeNewswire 2022-03-14 aTyr Pharma Announces Fourth Quarter and Full Year 2021 Results and Provides Corporate Update

GlobeNewswire 2022-02-10 Finch Therapeutics Announces Additions to Senior Leadership Team

GlobeNewswire 2022-01-04 Kamran Tahamtanzadeh Joins Inanovate, Inc. as New Chief Executive Officer

BNP Paribas Discount Zert LONN 26.../ DE000PC4JLP6 /

If you wish to receive reply to your feedback, please provide your email address.